Astellas Pharma Inc. (ALPMY)
OTCMKTS
· Delayed Price · Currency is USD
10.07
+0.50 (5.22%)
Apr 25, 2025, 4:00 PM EDT
Astellas Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 25, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 17,844 | 17,292 | 19,482 | 25,437 | 28,985 | 28,585 | Upgrade
|
| Market Cap Growth | -11.24% | -11.24% | -23.41% | -12.24% | 1.40% | -0.95% | Upgrade
|
| Enterprise Value | 22,311 | 22,203 | 23,576 | 22,597 | 26,106 | 25,824 | Upgrade
|
| Last Close Price | 10.07 | 9.66 | 10.75 | 14.20 | 15.58 | 15.44 | Upgrade
|
| PE Ratio | 52.65 | 51.03 | 172.88 | 34.26 | 28.37 | 26.22 | Upgrade
|
| PS Ratio | 1.40 | 1.35 | 1.84 | 2.23 | 2.72 | 2.53 | Upgrade
|
| PB Ratio | 1.77 | 1.71 | 1.85 | 2.24 | 2.41 | 2.28 | Upgrade
|
| P/TBV Ratio | - | - | - | 5.48 | 6.59 | 7.02 | Upgrade
|
| P/FCF Ratio | 16.96 | 16.44 | 21.92 | 11.61 | 15.53 | 11.48 | Upgrade
|
| P/OCF Ratio | 13.74 | 13.31 | 17.09 | 10.32 | 13.67 | 10.30 | Upgrade
|
| EV/Sales Ratio | 1.68 | 1.74 | 2.22 | 1.98 | 2.45 | 2.29 | Upgrade
|
| EV/EBITDA Ratio | 7.44 | 7.70 | 12.63 | 8.90 | 10.64 | 8.83 | Upgrade
|
| EV/EBIT Ratio | 13.83 | 14.30 | 28.62 | 12.97 | 14.53 | 11.38 | Upgrade
|
| EV/FCF Ratio | 21.21 | 21.11 | 26.53 | 10.31 | 13.98 | 10.37 | Upgrade
|
| Debt / Equity Ratio | 0.55 | 0.55 | 0.63 | 0.14 | 0.15 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 1.93 | 1.93 | 3.57 | 0.61 | 0.72 | 0.86 | Upgrade
|
| Debt / FCF Ratio | 5.28 | 5.28 | 7.50 | 0.70 | 0.94 | 1.01 | Upgrade
|
| Asset Turnover | 0.55 | 0.55 | 0.53 | 0.63 | 0.56 | 0.54 | Upgrade
|
| Inventory Turnover | 1.28 | 1.28 | 1.38 | 1.76 | 1.60 | 1.56 | Upgrade
|
| Quick Ratio | 0.79 | 0.79 | 0.69 | 1.13 | 1.05 | 1.15 | Upgrade
|
| Current Ratio | 1.13 | 1.13 | 0.93 | 1.45 | 1.34 | 1.47 | Upgrade
|
| Return on Equity (ROE) | 3.26% | 3.26% | 1.10% | 6.65% | 8.72% | 9.01% | Upgrade
|
| Return on Assets (ROA) | 4.21% | 4.21% | 2.58% | 6.05% | 5.92% | 6.83% | Upgrade
|
| Return on Capital (ROIC) | 5.98% | 5.98% | 3.61% | 8.55% | 8.17% | 9.31% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.20% | 10.20% | 5.50% | 13.40% | 13.30% | 14.90% | Upgrade
|
| Earnings Yield | 1.90% | 1.96% | 0.58% | 2.92% | 3.52% | 3.81% | Upgrade
|
| FCF Yield | 5.89% | 6.08% | 4.56% | 8.62% | 6.44% | 8.71% | Upgrade
|
| Dividend Yield | 5.02% | 5.12% | 4.30% | 3.18% | 2.64% | 2.46% | Upgrade
|
| Payout Ratio | 254.19% | 254.19% | 684.38% | 101.66% | 68.69% | 63.15% | Upgrade
|
| Buyback Yield / Dilution | 0.14% | 0.14% | 1.39% | 1.38% | 0.41% | 1.03% | Upgrade
|
| Total Shareholder Return | 5.16% | 5.25% | 5.70% | 4.56% | 3.05% | 3.49% | Upgrade
|
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.